SELLAS Life Sciences (SLS) EPS (Basic) (2020 - 2023)
Historic EPS (Basic) for SELLAS Life Sciences (SLS) over the last 7 years, with Q4 2023 value amounting to -$0.29.
- SELLAS Life Sciences' EPS (Basic) rose 3153.98% to -$0.29 in Q4 2023 from the same period last year, while for Sep 2024 it was -$0.12, marking a year-over-year increase of 9132.03%. This contributed to the annual value of -$1.36 for FY2023, which is 3599.45% up from last year.
- According to the latest figures from Q4 2023, SELLAS Life Sciences' EPS (Basic) is -$0.29, which was up 3153.98% from -$0.33 recorded in Q3 2023.
- Over the past 5 years, SELLAS Life Sciences' EPS (Basic) peaked at -$0.16 during Q1 2021, and registered a low of -$1.05 during Q1 2022.
- Its 4-year average for EPS (Basic) is -$0.46, with a median of -$0.42 in 2021.
- As far as peak fluctuations go, SELLAS Life Sciences' EPS (Basic) skyrocketed by 7575.76% in 2021, and later crashed by 55625.0% in 2022.
- SELLAS Life Sciences' EPS (Basic) (Quarter) stood at -$0.47 in 2020, then rose by 9.84% to -$0.42 in 2021, then dropped by 2.38% to -$0.43 in 2022, then soared by 31.54% to -$0.29 in 2023.
- Its last three reported values are -$0.29 in Q4 2023, -$0.33 for Q3 2023, and -$0.32 during Q2 2023.